Philippe Nuss
Overview
Explore the profile of Philippe Nuss including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
685
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hazarosova R, Momchilova A, Vitkova V, Yordanova V, Kostadinova A, Angelova M, et al.
Membranes (Basel)
. 2023 Dec;
13(12).
PMID: 38132913
Resveratrol (Resv) is considered to exert a beneficial impact due to its radical scavenger, anti-microbial and anti-inflammatory properties through several mechanisms that could include its interaction with the cell plasma...
2.
Fond G, Falissard B, Nuss P, Collin C, Duret S, Rabbani M, et al.
Mol Psychiatry
. 2023 Jul;
28(12):5328-5336.
PMID: 37479782
An important step to improve outcomes for patients with schizophrenia is to understand treatment patterns in routine practice. The aim of the current study was to describe the long-term management...
3.
Boyer L, Falissard B, Nuss P, Collin C, Duret S, Rabbani M, et al.
Mol Psychiatry
. 2023 Jul;
28(9):3709-3716.
PMID: 37479781
This mirror-image study aimed to evaluate the real-life effectiveness of long-acting injectable antipsychotics (LAI) in schizophrenia. Patients with schizophrenia initiating LAIs January 2015-December 2016 were enrolled from the French National...
4.
Yordanova V, Hazarosova R, Vitkova V, Momchilova A, Robev B, Nikolova B, et al.
Int J Mol Sci
. 2023 Jul;
24(13).
PMID: 37446342
The interplay between inflammatory and redox processes is a ubiquitous and critical phenomenon in cell biology that involves numerous biological factors. Among them, secretory phospholipases A (sPLA) that catalyze the...
5.
Adrien V, Bosc N, Fumat H, Tessier C, Ferreri F, Mouchabac S, et al.
Front Psychiatry
. 2023 Feb;
14:1089724.
PMID: 36816405
Schizophrenia is a severe, chronic, and heterogeneous mental disorder that affects approximately 1% of the world population. Ongoing research aims at clustering schizophrenia heterogeneity into various "biotypes" to identify subgroups...
6.
Baccouch R, Shi Y, Vernay E, Mathelie-Guinlet M, Taib-Maamar N, Villette S, et al.
Biochim Biophys Acta Biomembr
. 2022 Nov;
1865(2):184084.
PMID: 36368636
The lipid composition of cellular membranes and the balance between the different lipid components can be impacted by aging, certain pathologies, specific diets and other factors. This is the case...
7.
Nuss P, Corruble E, Baloche E, Garay R, Llorca P
Expert Rev Neurother
. 2022 Aug;
22(8):639-653.
PMID: 35913401
Introduction: Acute behavioral disturbances in psychosis, including agitation, comprise a heterogeneous group of manifestations varying in intensity and duration they last for. They require rapid, non-coercive treatments ranging from verbal...
8.
Llorca P, Nuss P, Fakra E, Alamome I, Drapier D, El Hage W, et al.
BMC Psychiatry
. 2022 Jun;
22(1):364.
PMID: 35643542
Background: Aripiprazole is a second-generation antipsychotic, efficacious in patients with schizophrenia during acute episodes. Due to its pharmacological profile, aripiprazole may be of interest in patients with specific clinical profiles...
9.
Tsoneva I, Semkova S, Bakalova R, Zhelev Z, Nuss P, Staneva G, et al.
Biophys Chem
. 2022 May;
286:106819.
PMID: 35605496
This review focuses on electrochemotherapy that consists in the delivery of anti-cancer drugs using high-voltage electrical pulses. Technical issues, choice of drugs, and protocol of drug delivery are still under...
10.
Dezecache G, Martin J, Tessier C, Safra L, Pitron V, Nuss P, et al.
PLoS One
. 2021 Dec;
16(12):e0260392.
PMID: 34874974
Reactions to danger have been depicted as antisocial but research has shown that supportive behaviors (e.g., helping injured others, giving information or reassuring others) prevail in life-threatening circumstances. Why is...